Krystal Biotech Inc. (KRYS)
NASDAQ · Healthcare
Krystal Biotech Inc. PE Ratio 2017–2026
Current and historical P/E ratio for Krystal Biotech Inc. (KRYS), calculated by dividing the latest closing price by the trailing twelve-month earnings per share (EPS). As of March 31, 2026 it is 34.53.
From: 09/30/2025To: 03/31/2026
Stock Price
TTM Net EPS
PE Ratio
Krystal Biotech Inc. PE Ratio — FAQ
Krystal Biotech Inc. (KRYS) pe ratio over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KRYS's pe ratio history?
The chart and table above show Krystal Biotech Inc.'s pe ratio by year and by quarter, including the growth rate.